From Bloomberg Markets and Finance.

Under new leadership from Dr. Marty Makary, the FDA is undergoing sweeping reforms to restore public trust, prioritize transparency and modernize drug oversight. Learn more about his approach on the latest "Wall Street Week" https://bloom.bg/44NT0wH